Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by heterogeneous pathophysiol...
With dementia diagnoses in the UK projected to exceed one million in 2025, there is an urgent need f...
Dementia poses an escalating global health burden, yet its underlying mechanisms remain incompletely...
To leverage sleep foundation models trained on large datasets of polysomnography for neurological di...
Cognitive function can decline irreversibly with age, potentially progressing to dementia. Intervent...
Genetic risk factors for neuropsychiatric disorders are well documented. However, some individuals w...
Interpretable scoring system can contribute to bridge the gap between the timeliness and complexity ...
Early identification of dementia risk is essential for preventive care and timely enrolment into dis...
There is need to detect and intervene in pre-clinical phases of Alzheimer’s disease (AD). Electronic...
Alzheimers disease (AD) remains a major global health challenge, with growing evidence linking chron...
Alzheimer’s disease (AD) genome-wide association studies (GWAS), typically based on clinical phenoty...
Blood-based metabolomic signatures offer promising, non-invasive avenues for Alzheimer’s disease (AD...
Large language models (LLMs) offer new opportunities to synthesize the vast and heterogeneous biomed...
This study aimed to develop an artificial intelligence (AI) algorithm capable of distinguishing Alzh...
Cognitive impairment (CI) is often under detected in primary care due to time and resource constrain...
Cerebral small vessel disease (CSVD) is a leading cause of age-related cognitive decline and neurolo...
To identify clusters of high-cost patients in England based on diagnoses and sociodemographic charac...
Alzheimer’s disease (AD) exhibits profound spatial heterogeneity in its molecular and pathological f...
The majority of causal genome-wide association studies (GWAS) variants for Alzheimer’s disease (AD) ...
Mild cognitive impairment (MCI) is an intermediate stage between normal ageing and dementia, with af...
Parkinson’s Disease (PD) is the most prevalent neurodegenerative disorder after Alzheimer’s, yet its...